Your browser doesn't support javascript.
loading
Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
Häselbarth, Lukas; Gamali, Sara; Saul, Domenica; Krumbholz, Manuela; Böttcher-Loschinski, Romy; Böttcher, Martin; Zou, Deyu; Metzler, Markus; Karow, Axel; Mougiakakos, Dimitrios.
Afiliación
  • Häselbarth L; Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany. lukas.haeselbarth@uk-erlangen.de.
  • Gamali S; Comprehensive Cancer Center Erlangen-European Metropolitan Area Nuremberg (CCC-ER-EMN), Erlangen, Germany. lukas.haeselbarth@uk-erlangen.de.
  • Saul D; Interdisciplinary Centre for Clinical Research (IZKF), Erlangen, Germany. lukas.haeselbarth@uk-erlangen.de.
  • Krumbholz M; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Böttcher-Loschinski R; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Böttcher M; Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
  • Zou D; Comprehensive Cancer Center Erlangen-European Metropolitan Area Nuremberg (CCC-ER-EMN), Erlangen, Germany.
  • Metzler M; Department of Hematology and Oncology, Medical Center, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany.
  • Karow A; Department of Hematology and Oncology, Medical Center, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany.
  • Mougiakakos D; Health Campus Immunology, Inflammation and Infectiology (GC-I3), Medical Center, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany.
BMC Cancer ; 23(1): 1153, 2023 Nov 27.
Article en En | MEDLINE | ID: mdl-38012567
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido